Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]

Yinlong Chen, Wenli Zhan, Ke Shen, Manqing Peng, Qingliang Zheng

Open source

DOI
10.1016/j.trsl.2026.09.003
Published
2026-11
Container
Translational Research
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trsl.2026.09.003,
  title = {Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]},
  author = {Yinlong Chen and Wenli Zhan and Ke Shen and Manqing Peng and Qingliang Zheng},
  year = {2026},
  journal = {Translational Research},
  doi = {10.1016/j.trsl.2026.09.003},
  url = {https://doi.org/10.1016/j.trsl.2026.09.003}
}

RIS

TY  - JOUR
TI  - Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]
AU  - Yinlong Chen
AU  - Wenli Zhan
AU  - Ke Shen
AU  - Manqing Peng
AU  - Qingliang Zheng
PY  - 2026
JO  - Translational Research
DO  - 10.1016/j.trsl.2026.09.003
UR  - https://doi.org/10.1016/j.trsl.2026.09.003
ER  - 

APA

Chen, Y., Zhan, W., Shen, K., Peng, M., & Zheng, Q. (2026). Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]. Translational Research. https://doi.org/10.1016/j.trsl.2026.09.003

Source records